Relapsed/refractory HER2+ metastatic breast cancer Editorial
| Authors: | Brufsky, A. M.; Gadi, V. K.; Hurvitz, S. A.; Iyengar, N. M. |
| Title: | Relapsed/refractory HER2+ metastatic breast cancer |
| Keywords: | clinical article; overall survival; cancer recurrence; note; capecitabine; progression free survival; multiple myeloma; phase 2 clinical trial; breast cancer; docetaxel; interstitial lung disease; stereotactic radiosurgery; phase 1 clinical trial; dna topoisomerase inhibitor; disease control; insulin dependent diabetes mellitus; metastatic breast cancer; disease exacerbation; epidermal growth factor receptor kinase inhibitor; pertuzumab; central nervous system metastasis; overall response rate; trastuzumab emtansine; crizotinib; human epidermal growth factor receptor 2 positive breast cancer; human; antibody drug conjugate |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 35 |
| Issue: | 4 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2021-04-01 |
| Start Page: | 215 |
| End Page: | 219 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Export Date: 1 June 2022 -- Source: Scopus |
MSK Authors
-
134Iyengar